Search research articles
Contact Us
Filters
Showing results (221-230 of 263) with videos related to
Page
of 27
Sort By:
Plos Genetics
|
January 28, 2014
Differential effects of collagen prolyl 3-hydroxylation on skeletal tissues
Erica P Homan, Caressa Lietman, Ingo Grafe, et al.
Pediatric Blood & Cancer
|
November 15, 2019
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)
Eric S Schafer, Rachel E Rau, Stacey L Berg, et al.
Circulation
|
December 25, 2014
Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia
Takayuki Iriyama, Kaiqi Sun, Nicholas F Parchim, et al.
Molecular Cancer Research : MCR
|
June 24, 2008
Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma
Xin-Yan Lu, Yaojuan Lu, Yi-Jue Zhao, et al.
Radiology
|
July 18, 2017
Association between Testicular Microlithiasis and Testicular Neoplasia: Large Multicenter Study in a Pediatric Population
Andrew T Trout, Jeanne Chow, Erin R McNamara, et al.
Pediatric Blood & Cancer
|
October 10, 2013
Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease
Stephen J Simko, Huy D Tran, Jeremy Jones, et al.
Hematological Oncology
|
February 21, 2017
The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis
Leomar Y Ballester, Miguel D Cantu, Karen P H Lim, et al.
Blood Advances
|
December 11, 2025
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
Sasanka M Handunnetti, Amit Khot, Piers Blombery, et al.
Nature Communications
|
June 29, 2021
Restoration of the molecular clock is tumor suppressive in neuroblastoma
Myrthala Moreno-Smith, Giorgio Milazzo, Ling Tao, et al.
Nature Communications
|
June 28, 2022
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Ling Tao, Mahmoud A Mohammad, Giorgio Milazzo, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 263) with videos related to
Sort By:
Page
of 27
Plos Genetics
|
January 28, 2014
Differential effects of collagen prolyl 3-hydroxylation on skeletal tissues
Erica P Homan, Caressa Lietman, Ingo Grafe, et al.
Pediatric Blood & Cancer
|
November 15, 2019
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)
Eric S Schafer, Rachel E Rau, Stacey L Berg, et al.
Circulation
|
December 25, 2014
Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia
Takayuki Iriyama, Kaiqi Sun, Nicholas F Parchim, et al.
Molecular Cancer Research : MCR
|
June 24, 2008
Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma
Xin-Yan Lu, Yaojuan Lu, Yi-Jue Zhao, et al.
Radiology
|
July 18, 2017
Association between Testicular Microlithiasis and Testicular Neoplasia: Large Multicenter Study in a Pediatric Population
Andrew T Trout, Jeanne Chow, Erin R McNamara, et al.
Pediatric Blood & Cancer
|
October 10, 2013
Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease
Stephen J Simko, Huy D Tran, Jeremy Jones, et al.
Hematological Oncology
|
February 21, 2017
The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis
Leomar Y Ballester, Miguel D Cantu, Karen P H Lim, et al.
Blood Advances
|
December 11, 2025
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
Sasanka M Handunnetti, Amit Khot, Piers Blombery, et al.
Nature Communications
|
June 29, 2021
Restoration of the molecular clock is tumor suppressive in neuroblastoma
Myrthala Moreno-Smith, Giorgio Milazzo, Ling Tao, et al.
Nature Communications
|
June 28, 2022
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Ling Tao, Mahmoud A Mohammad, Giorgio Milazzo, et al.
Page
of 27